Magnesium: Its proven and potential clinical significance

Southern Medical Journal

Volumn 94, Issue 12, 2001, Pages 1195-1201

  Fox, Chester ^a   Ramsoomair, Delano ^a   Carter, Cathleen ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MAGNESIUM;

ARTICLE; ASTHMATIC STATE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAGNESIUM DEFICIENCY; PREECLAMPSIA; TORSADE DES POINTES;

EID: 0035693347     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200112000-00013     Document Type: Article

References (67)

1. Magnesium: Growing in clinical importance
2. Magnesium, hypertensive vascular diseases, atherogenesis, subcellular compartmentation of calcium and magnesium and vascular contractility
3. Magnesium in the pathophysiology and treatment of hypertension and diabetes mellitus: Where are we in 1997?
4. Magnesium metabolism and deficiency
5. Hypertension, diabetes, and insulin resistance: The role of intercellular magnesium
6. Magnesium homeostasis and clinical disorders of magnesium deficiency
7. Physiology of magnesium metabolism and the important role of magnesium in potassium deficiency
8. Relation of cardiovascular disease to potassium and magnesium deficiencies
9. NMR studies of intracellular metal ions in intact cells and tissues
10. Blood pressure lowering by pioglitazone: Evidence for direct vascular effect
11. Laboratory tests for the assessment of magnesium status in humans
12. Determination of serum magnesium concentration by clinical laboratories
13. Magnesium and its therapeutic uses: A review
14. Effects of dietary sodium and magnesium on cyclosporin A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats
15. Magnesium supplementation in mild hypertensive patients on a moderately low sodium diet
16. Pilot evaluation of the putative antihypertensive effect of magnesium
17. Increased activity of the magnesium-sodium exchanger in red blood cells for essential hypertensive patients
18. Effects of magnesium on blood pressure and intracellular ions of Brazilian hypertensive patients
19. Intracellular free magnesium in erythrocytes of essential hypertension: Relation to blood pressure and serum bivalent cations
20. Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: Effect on magnesium
21. Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid-salt sensitive rats but not in normotensive rats
22. Electrolyte content of serum, erythrocyte, kidney, and heart tissue in salt induced hypertensive rats
23. Effect of dietary magnesium supplementation on intralymphocytic free calcium and magnesium in stroke-prone spontaneously hypertensive rats
24. Magnesium, hypertensive vascular diseases, atherogenesis, subcellular compartmentation of calcium and magnesium and vascular contractility
25. The effect of angiotenstin II on platelet intracellular free magnesium and calcium ionic concentrations in essential hypertension
26. Hypertension and associated abnormalities-the role of insulin resistance and the sympathoadrenal system
27. A high prevalence of hypomagnesemia in hospitalized patients
28. Parenteral magnesium tolerance testing in the evaluation of magnesium deficiency
29. Hypomagnesemia in diabetes
30. An investigation of hypomagnesemia among ambulatory urban African Americans
31. Water hardness and cardiovascular diseases
32. Magnesium and calcium in drinking water and death from acute myocardial infarction in women
33. Magnesium in drinking water and ischemic heart disease
34. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study
35. Effect of dietary magnesium supplementation in the prevention of coronary heart disease and sudden cardiac death
36. Serum calcium and magnesium levels after glucagon in children with diabetes
37. Renal hypomagnesemia in human diabetes mellitus: Its relation to glucose homeostasis
38. Magnesium levels in plasma, erythrocyte, and urine in patients with diabetes mellitus
39. Magnesium interrelationship in ischemic heart disease: A review
40. Digitalis toxicity and hypomagnesemia
41. Magnesium therapy for intractable ventricular tachyarrhythmias in normal magnesemic patients
42. Intravenous magnesium therapy and acute myocardial infarction
43. Beneficial effect of magnesium sulfate in acute myocardial infarction
44. Intravenous magnesium sulfate in suspected acute myocardial infarction: Results of the second Leicester intravenous magnesium intervention trial (LIMIT-2)
45. Fourth international study of infarct survival: Protocol for a large simple study of the effects of oral mononitrate, oral captopril, and of intravenous magnesium
46. Adjunctive drug therapy of acute myocardial infarction-evidence from clinical trials
47. Magnesium sulfate: Rationale for its use in preeclampsia
48. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years
49. Magnesium supplementation in the treatment of diabetes
50. Effects of magnesium supplementation in hypertensive patients: Assessment by home, office, and ambulatory blood pressures
51. Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure (TOHP Study)
52. Hypomagnesemia in type II diabetes: Effect of a three-month replacement therapy
53. Effects of oral magnesium supplementation on plasma lipid concentrations of patients with non-insulin-dependent diabetes mellitus
54. Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics
55. Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: A double-blind cross-over study
56. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension
57. New data about the effects of oral physiological magnesium supplementation on several cardiovascular risk factors
58. The dose-dependent reduction in blood pressure through administration of magnesium
59. Long-term magnesium supplementation in essential hypertension
60. Effects of dietary magnesium supplementation on diurnal variations of blood pressure and plasma sodium, potassium-ATPase activity in essential hypertension
61. Blood pressure response during long-term treatment with magnesium is dependent on magnesium status
62. Oral magnesium supplementation in patients with essential hypertension
63. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease
64. Intracellular magnesium deficiency and effect of oral magnesium on blood pressure and red cell sodium transport in diuretic-treated hypertensive patients
65. Effects of oral magnesium on blood pressure and red cell sodium transport in patients receiving long-term thiazide diuretics for hypertension
66. Lack of effect of oral magnesium on high blood pressure
67. Effect of magnesium on blood pressure